No Data
Hims & Hers Health 1Q Revenue Jumps; 2Q Sales Outlook Misses Analyst Expectations
Express News | Hims & Hers Shares Down 4.7% Premarket After Q1 Results
Earnings Call Summary | Hims & Hers Health(HIMS.US) Q1 2025 Earnings Conference
Express News | In overnight trading, Palantir drops 9% despite earnings beating, healthcare platform Hims & Hers Health falls 4% for lower-than-expectation outlooks. WeRide rallies 14%, it expands strategic partnership with Uber.
Hims Outlines 2030 Targets With $6.5B Revenue and $1.3B EBITDA Projections
Stocks to Watch: Ford, Palantir Technologies, Hims & Hers Health, Jeld-Wen